562 related articles for article (PubMed ID: 30598172)
41. A critical appraisal and implications of the new National Institute for Health and Care Excellence guideline on dupilumab for treating moderate-to-severe atopic eczema.
Weidinger S; Apfelbacher C
Br J Dermatol; 2019 Mar; 180(3):435-437. PubMed ID: 30821391
[No Abstract] [Full Text] [Related]
42. New insights on ocular surface disease in patients with atopic dermatitis treated with dupilumab.
Bortoluzzi P; Ferrucci S; Galimberti D; Garavelli F; Pozzo Giuffrida F; Pizzati A; Marzano AV; Mapelli C
Br J Dermatol; 2022 Jan; 186(1):186-187. PubMed ID: 34431510
[TBL] [Abstract][Full Text] [Related]
43. New and Emerging Biologics for Atopic Dermatitis.
Baghoomian W; Na C; Simpson EL
Am J Clin Dermatol; 2020 Aug; 21(4):457-465. PubMed ID: 32323259
[TBL] [Abstract][Full Text] [Related]
44. What's new in atopic eczema? An analysis of systematic reviews published in 2018. Part 2: systemic therapies.
Olabi B; Worboys S; Garland T; Grindlay DJC; Rogers NK; Harman KE
Clin Exp Dermatol; 2020 Dec; 45(8):980-985. PubMed ID: 32568435
[TBL] [Abstract][Full Text] [Related]
45. Effectiveness of dupilumab treatment in 95 patients with atopic dermatitis: daily practice data.
de Wijs LEM; Bosma AL; Erler NS; Hollestein LM; Gerbens LAA; Middelkamp-Hup MA; Kunkeler ACM; Nijsten TEC; Spuls PI; Hijnen DJ
Br J Dermatol; 2020 Feb; 182(2):418-426. PubMed ID: 31145810
[TBL] [Abstract][Full Text] [Related]
46. Real-world persistence with dupilumab among adults with atopic dermatitis.
Silverberg JI; Guttman-Yassky E; Gadkari A; Kuznik A; Mallya UG; Mastey V; Zhang H; Chen Z; Chen C; Korotzer A; Sierka D; Fenton MC; Kaur M; Jalbert JJ
Ann Allergy Asthma Immunol; 2021 Jan; 126(1):40-45. PubMed ID: 32739313
[TBL] [Abstract][Full Text] [Related]
47. Off-label use of dupilumab for pediatric patients with atopic dermatitis: A multicenter retrospective review.
Igelman S; Kurta AO; Sheikh U; McWilliams A; Armbrecht E; Jackson Cullison SR; Kress DW; Smith A; Castelo-Soccio L; Treat J; Boothe WD; Diaz LZ; Levy ML; Patel A; Lee LW; Fraile-Alonso MC; Antaya RJ; Shah S; Kittler N; Arkin L; Siegfried E
J Am Acad Dermatol; 2020 Feb; 82(2):407-411. PubMed ID: 31606479
[TBL] [Abstract][Full Text] [Related]
48. Atopic dermatitis-like graft-versus-host disease treated with dupilumab.
Larijani M; Zarowin D; Wohlschlaeger A; Perman MJ; Treat JR
Pediatr Dermatol; 2023 Mar; 40(2):320-322. PubMed ID: 36268606
[TBL] [Abstract][Full Text] [Related]
49. The beginning of biological treatment era in the atopic dermatitis management.
D'erme AM
Dermatol Ther; 2016 May; 29(3):208-9. PubMed ID: 26331894
[No Abstract] [Full Text] [Related]
50. Review of Systemic Treatment Options for Adult Atopic Dermatitis.
Gooderham M; Lynde CW; Papp K; Bourcier M; Guenther L; Gulliver W; Hong CH; Poulin Y; Sussman G; Vender R
J Cutan Med Surg; 2017; 21(1):31-39. PubMed ID: 27635033
[TBL] [Abstract][Full Text] [Related]
51. EAACI Biologicals Guidelines-dupilumab for children and adults with moderate-to-severe atopic dermatitis.
Agache I; Akdis CA; Akdis M; Brockow K; Chivato T; Del Giacco S; Eiwegger T; Eyerich K; Giménez-Arnau A; Gutermuth J; Guttman-Yassky E; Maurer M; Ogg G; Ong PY; O'Mahony L; Schwarze J; Warner A; Werfel T; Palomares O; Jutel M
Allergy; 2021 Apr; 76(4):988-1009. PubMed ID: 33538044
[TBL] [Abstract][Full Text] [Related]
52. Comparison of Old and New Systemic Treatments for Moderate to Severe Atopic Dermatitis.
Yim HJ; Jean T; Ong PY
Curr Allergy Asthma Rep; 2024 May; 24(5):289-301. PubMed ID: 38632138
[TBL] [Abstract][Full Text] [Related]
53. Management of Severe Atopic Dermatitis in Pediatric Patients.
Mancuso JB; Lee SS; Paller AS; Ohya Y; Eichenfield LF
J Allergy Clin Immunol Pract; 2021 Apr; 9(4):1462-1471. PubMed ID: 33838839
[TBL] [Abstract][Full Text] [Related]
54. [Analysis of a case series of adult patients with severe atopic dermatitis treated with dupilumab in Argentina].
Máspero J; Angles MV; Ardusso L; Brancciforte M; Castro C; Cruz Iturrieta C; Chouela E; De Gennaro MS; Fernández Bussy R; Galimberti ML; Galimberti RL; Gattolin G; Luna PC; Magariños G; Marini MG; Maskin M; Plafnik R; Raimondo N; Russo JP; Sevinsky L; Stringa MF
Rev Fac Cien Med Univ Nac Cordoba; 2020 Jun; 77(2):94-99. PubMed ID: 32558511
[TBL] [Abstract][Full Text] [Related]
55. Patient burden of moderate to severe atopic dermatitis (AD): Insights from a phase 2b clinical trial of dupilumab in adults.
Simpson EL; Bieber T; Eckert L; Wu R; Ardeleanu M; Graham NM; Pirozzi G; Mastey V
J Am Acad Dermatol; 2016 Mar; 74(3):491-8. PubMed ID: 26777100
[TBL] [Abstract][Full Text] [Related]
56. A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitis.
Fargnoli MC; Esposito M; Ferrucci S; Girolomoni G; Offidani A; Patrizi A; Peris K; Costanzo A; Malara G; Pellacani G; Romanelli M; Amerio P; Cristaudo A; Flori ML; Motolese A; Betto P; Patruno C; Pigatto P; Peccianti C; Stinco G; Zalaudek I; Bianchi L; Boccaletti V; Cannavo SP; Cusano F; Lembo S; Mozzillo R; Gallo R; Potenza C; Rongioletti F; Tiberio R; Grieco T; Micali G; Persechino S; Pettinato M; Pucci S; Stingeni L; Caruso C; Argenziano G;
J Dermatolog Treat; 2022 Mar; 33(2):1146-1149. PubMed ID: 32436765
[No Abstract] [Full Text] [Related]
57. Patient-Reported Outcome Measures in Atopic Dermatitis and Chronic Hand Eczema in Adults.
Barrett A; Hahn-Pedersen J; Kragh N; Evans E; Gnanasakthy A
Patient; 2019 Oct; 12(5):445-459. PubMed ID: 31270775
[TBL] [Abstract][Full Text] [Related]
58. Eczema control and treatment satisfaction in atopic dermatitis patients treated with dupilumab - a cross-sectional study from the BioDay registry.
Oosterhaven JAF; Spekhorst LS; Zhang J; Voorberg AN; Romeijn GLE; Boesjes CM; de Graaf M; de Bruin-Weller MS; Schuttelaar MLA
J Dermatolog Treat; 2022 Jun; 33(4):1986-1989. PubMed ID: 34151695
[TBL] [Abstract][Full Text] [Related]
59. When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council.
Simpson EL; Bruin-Weller M; Flohr C; Ardern-Jones MR; Barbarot S; Deleuran M; Bieber T; Vestergaard C; Brown SJ; Cork MJ; Drucker AM; Eichenfield LF; Foelster-Holst R; Guttman-Yassky E; Nosbaum A; Reynolds NJ; Silverberg JI; Schmitt J; Seyger MMB; Spuls PI; Stalder JF; Su JC; Takaoka R; Traidl-Hoffmann C; Thyssen JP; van der Schaft J; Wollenberg A; Irvine AD; Paller AS
J Am Acad Dermatol; 2017 Oct; 77(4):623-633. PubMed ID: 28803668
[TBL] [Abstract][Full Text] [Related]
60. Risk of infection in patients with atopic dermatitis treated with dupilumab: A meta-analysis of randomized controlled trials.
Fleming P; Drucker AM
J Am Acad Dermatol; 2018 Jan; 78(1):62-69.e1. PubMed ID: 28987493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
